Dräger makes sustainability and quality an Executive Board responsibility
|
EQS-News: Drägerwerk AG & Co. KGaA
/ Key word(s): Personnel/Sustainability
Dräger makes sustainability and quality an Executive Board responsibility Stefanie Hirsch will be appointed to the Executive Board as of July 1, 2024 Dräger is creating a new, additional Executive Board position for sustainability and quality. At its meeting today, the Supervisory Board of Drägerwerk Verwaltungs AG decided to appoint Stefanie Hirsch to the Executive Board as Chief Sustainability and Quality Officer as of July 1, 2024. "Sustainability has always been deeply rooted in Dräger's corporate culture and is becoming increasingly important for the future. It is a cross-cutting topic and affects all processes and areas of our company. The same applies to quality, one of our four strengths and a cornerstone of our company. I am delighted to have Stefanie Hirsch as an experienced and committed colleague on the Executive Board." - Stefan Dräger, CEO of Drägerwerk Verwaltungs AG. Stefanie Hirsch was born in Worms, Germany in 1975 and studied biotechnology at Mannheim University of Applied Sciences. She began her professional career at Abbott Diagnostics in the Research & Development department. This was followed by various management positions in the areas of Operations, Quality and Regulatory Affairs, including abroad. She has also worked at Ortho-Clinical Diagnostics, a global provider of products and services for transfusion services and clinical laboratories, where she led the quality management and regulatory affairs teams in the company's international sales & service offices in the EMEA and Asia regions. Hirsch has been with Dräger since 2018 and is Head of Quality and Regulatory Affairs in Medical Technology. She has also been Head of Corporate Quality & Regulatory Affairs, including Global Environmental Health and Safety Management, since 2020. Photo: Stefanie Hirsch will be appointed to the Executive Board of Drägerwerk Verwaltungs AG as of July 1, 2024. © Drägerwerk AG & Co. KGaA
Dräger. Technology for Life®
08.05.2024 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG. |
| Language: | English |
| Company: | Drägerwerk AG & Co. KGaA |
| Moislinger Allee 53-55 | |
| 23558 Lübeck | |
| Germany | |
| Phone: | +49 (0)451 882-0 |
| Fax: | +49 (0)451 882-2080 |
| E-mail: | info@draeger.com |
| Internet: | www.draeger.com |
| ISIN: | DE0005550602, DE 000 555 063 6, DE 000 555 071 9 |
| WKN: | 555060, 555063 Vorzüge, 555071 Genussschein D |
| Indices: | SDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1899015 |
| End of News | EQS News Service |
|
|
1899015 08.05.2024 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.